Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway (Onco-PREMs)
- Disease/Condition
- Cancer
- Drug/Device/Intervention
- Data collection
- Study type
- Observational
- Intervention type
- other
- Primary sponsor
- Institut Jean-Godinot
- Phase
- N/A
- Start date
- Jun 01, 2024
- End date
- Nov 01, 2025
- Enrollment
- 500 participants
Psychometric validation
Healthcare systems are evolving, giving increasing prominence to the patient-centered model,
 accompanied by objective and perceived outcomes.
 
 PREMs (Patient Reported Experience Measures) are used to assess how patients feel about their
 experience of care. PREMs enable patients to take an active role in their own care, and
 enable healthcare establishments to identify areas for improvement that can be incorporated
 into their quality processes.
 
 In oncology, the collection of patient-perceived quality regarding their care pathway would
 enable better coordination of their care. While a few initiatives have emerged in the field
 of PREMs, the development of a reliable questionnaire assessing patient perception of their
 care pathway in oncology remains a challenge.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06356363
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06356363 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut Jean-Godinot and is currently Not yet recruiting. The study focuses on Cancer. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.